Cited by 1,728Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsChronic Disease Management Strategies

The DOI matches its Crossref record; 156 of the 160 references it cites were found in a registry or an index.

Epidemiology of Heart Failure

Open access

Roger, Véronique L.·2013·Circulation Research

DOI 10.1161/circresaha.113.300268PMC PMC3806290

Open this paper in CoChat — free account Open PDF

Abstract

Heart failure (HF) has been singled out as an epidemic and is a staggering clinical and public health problem, associated with significant mortality, morbidity, and healthcare expenditures, particularly among those aged ≥65 years. The case mix of HF is changing over time with a growing proportion of cases presenting with preserved ejection fraction for which there is no specific treatment. Despite progress in reducing HF-related mortality, hospitalizations for HF remain frequent and rates of readmissions continue to rise. To prevent hospitalizations, a comprehensive characterization of predictors of readmission in patients with HF is imperative and must integrate the impact of multimorbidity related to coexisting conditions. New models of patient-centered care that draw on community-based resources to support HF patients with complex coexisting conditions are needed to decrease hospitalizations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circresaha.113.300268

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Self-citation
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Self-citation
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Nagueh, S. F., Appleton, C. P., Gillebert, T. C., Marino, P. N., Oh, J. K., Smiseth, O. A., Waggoner, A. D., Flachskampf, F. A., Pellikka, P. A., & Evangelista, A. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.023 · Cited by 4,367
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,209
Self-citation
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,137
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,739

Show all 160 references

Research works printed but not linked: 3

Joint Commission on Accreditation of Health Care Organizations. Specification Manual for National Implementation of Hospital Core Measures: Version 2.0-Implementation to Begin With July 2004 Discharges. Oakbrook Terrace, IL: Joint Commission on Accreditation of Health Care Organizations; 2004.
Lindenfeld J, Krause-Steinrauf H, Salerno J. Where are all the women with heart failure? J Am Coll Cardiol. 1997;30:1417–1419.
10.1001/jama.1996.03530430033035 · DOI

Sorted by citations

Items 701–800 of 1,002

CHRONIC HEART FAILURE COURSE PROGNOSIS DEPENDING ON BODY WEIGHT AND ENDOGENOUS INTOXICATION SYNDROME
Kondratyuk, M. O., Sorokopud, О. О., Strilchuk, L. M., Zhakun, I. B., Slaba, O., Беш, О., Radchenko, О. М., & Leshchuk, Y. (2019) · Wiadomości Lekarskie · doi:10.36740/wlek201904104 · Cited by 15
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats
Krasnova, M. V., Куликов, А. Н., Okovityi, S. V., Ivkin, D. Y., Карпов, А. А., Kaschina, E., & Smirnov, A. V. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01873-7 · Cited by 15
Cohort profile: FACE, prospective follow-up of chronic heart failure patients with sleep-disordered breathing indicated for adaptive servo ventilation
Tamisier, R., Damy, T., Davy, J., Verbraecken, J. A., Bailly, S., Lavergne, F., Palot, A., Goutorbe, F., Pépin, J., & d’Ortho, M. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038403 · Cited by 15
Mitoxantrone impairs proteasome activity and prompts early energetic and proteomic changes in HL-1 cardiomyocytes at clinically relevant concentrations
Costa, V. M., Capela, J. P., Sousa, J. R., Eleutério, R. P., Rodrigues, P. D. S., Dores‐Sousa, J. L., Carvalho, R. A., Bastos, M. D. L., Duarte, J. A., Remião, F., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02874-4 · Cited by 14
Education and heart failure: New insights from the atherosclerosis risk in communities study and mendelian randomization study
Liao, L., Zhuang, X., Zhang, S., Liao, X.-X., & Li, W. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.09.068 · Cited by 13
Increased Oxidative Stress During Exercise Predicts Poor Prognosis in Patients with Acute Decompensated Heart Failure
Shibata, A., Izumiya, Y., Yamaguchi, Y., Kitada, R., Iwata, S., Ehara, S., Izumi, Y., Hanatani, A., & Yoshiyama, M. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13538 · Cited by 15
Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication
Furuhashi, M., Muranaka, A., Yuda, S., Tanaka, M., Koyama, M., Kawamukai-Nishida, M., Takahashi, S., Higashiura, Y., Miyamori, D., Nishikawa, R., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.07.047 · Cited by 15
The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction
Pintér, A., Behon, A., Veres, B., Merkel, E. D., Schwertner, W. R., Kuthi, L. K., Masszi, R., Lakatos, B. K., Kovács, A. D., Becker, D. J., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12020517 · Cited by 16
Activation of the sigma-1 receptor exerts cardioprotection in a rodent model of chronic heart failure by stimulation of angiogenesis
Zhao, X., Liu, X. Z., Chen, X., Han, X., Sun, Y., Fo, Y., Wang, X., Qu, C., & Yang, B. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00517-1 · Cited by 15
Increased cardiac work provides a link between systemic hypertension and heart failure
Wilson, A. J., Wang, V. Y., Sands, G. B., Young, A. A., Nash, M. P., & LeGrice, I. J. (2017) · Physiological Reports · doi:10.14814/phy2.13104 · Cited by 15
ANMCO/SIC Consensus Document: cardiology networks for outpatient heart failure care
Aspromonte, N., Gulizia, M. M., Lenarda, A. D., Mortara, A., Battistoni, I., Maria, R. D., Gabriele, M., Iacoviello, M., Navazio, A., Pini, D., et al. (2017) · European Heart Journal Supplements · doi:10.1093/eurheartj/sux009 · Cited by 15
Circulating miR-192 is a Prognostic Marker in Patients With Ischemic Cardiomyopathy
Klenke, S., Eul, S., Peters, J., Neumann, T., Adamzik, M., & Frey, U. H. (2018) · Future Cardiology · doi:10.2217/fca-2017-0108 · Cited by 15
Efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a meta-analysis
Zhang, S., Zhang, F., Du, M., Huang, K., & Wang, C. (2019) · British Journal Of Nutrition · doi:10.1017/s000711451900014x · Cited by 15
Clinical Approach to Manage Gastrointestinal Bleeding with a Left Ventricular Assist Device (LVAD)
Ahsan, I., Faraz, A., Mehmood, A., Ullah, W., & Ghani, A. R. (2019) · Cureus · doi:10.7759/cureus.6341 · Cited by 15
Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial
Wang, Y., Wang, X., Wang, J., Li, B., Yu, R., Hu, Y., Li, X., Peng, G.-C., Zhang, M., & Zhu, M. (2020) · Trials · doi:10.1186/s13063-020-4208-4 · Cited by 15
Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
Amrute, J. M., Luo, X., Penna, V., Bredemeyer, A., Yamawaki, T., Heo, G. S., Shi, S., Koenig, A., Yang, S., Kadyrov, F., et al. (2022) · bioRxiv · doi:10.1101/2022.10.17.512579 · Cited by 14
Synergistic Effect of Disease Severity, Anxiety Symptoms and Elderly Age on the Quality of Life of Outpatients with Heart Failure
Figueiredo, J., de Oliveira, G. M. M., Pereira, B. D. B., Figueiredo, A. E. B., do Nascimento, E. M., Garcia, M. I., & Xavier, S. S. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190174 · Cited by 14
Education of the Patients Living with Heart Disease
Podvorica, E., Bekteshi, T., Oruqi, M., & Kalo, I. (2021) · Materia Socio Medica · doi:10.5455/msm.2021.33.10-15 · Cited by 16
“I Can’t Go Far”: Perceptions and Experiences of Heart Failure Patients Regarding Physical Activity: A Qualitative Study Using Semistructured Face-to-Face Interviews
Charuel, É., Bernard, M., Roussel, H. V., Cambon, B., Ménini, T., Lafarge, E., Dutheil, F., & Vorilhon, P. (2021) · Health Education & Behavior · doi:10.1177/10901981211053247 · Cited by 14
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness
Cavallari, I., Maddaloni, E., Nusca, A., Tuccinardi, D., Buzzetti, R., Pozzilli, P., & Grigioni, F. (2021) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-021-00508-3 · Cited by 14
Early Detection of Worsening Heart Failure in Patients at Home Using a New Telemonitoring System of Respiratory Stability
Sakoda, M., Asanoi, H., Ohtani, T., Nakamoto, K., Harada, D., Noto, T., Takagawa, J., Wada, O., Nakane, E., Inoko, M., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0590 · Cited by 14
A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
Ødegaard, K. M., Lirhus, S. S., Melberg, H. O., Hallén, J., & Halvorsen, S. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02522-y · Cited by 14
Heart Failure and Cardiomyopathies: CT and MR from Basics to Advanced Imaging
Palumbo, P., Cannizzaro, E., Palumbo, M. M., Cesare, A. D., Bruno, F., Acanfora, C., Arceri, A., Evangelista, L., Arrigoni, F., Grassi, F., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12102298 · Cited by 14
Health Risk Assessment with Federated Learning
Diamantoulaki, I., Diamantoulakis, P. D., Bouzinis, P. S., Sarigiannidis, P. G., & Karagiannidis, G. K. (2022) · International Balkan Conference on Communications and Networking (BalkanCom) · doi:10.1109/balkancom55633.2022.9900733 · Cited by 14
Association Between Progression of Arterial Stiffness and Left Ventricular Remodeling in a Community-Based Cohort
Yoshida, Y., Nakanishi, K., Jin, Z., Daimon, M., Ishiwata, J., Sawada, N., Hirokawa, M., Kaneko, H., Nakao, T., Mizuno, Y., et al. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100409 · Cited by 14
Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry
Bruno, F., Marengo, G., FILIPPO, O. D., Wańha, W., Leonardi, S., Raposeiras‐Roubín, S., Fabris, E., Popovic, M. B., Giannino, G., Truffa, A., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028475 · Cited by 16
Enhancing heart failure treatment decisions: interpretable machine learning models for advanced therapy eligibility prediction using EHR data
Zhang, Y., Golbus, J. R., Wittrup, E. M., Aaronson, K. D., & Najarian, K. (2024) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-024-02453-y · Cited by 16
Transforming growth factor beta-1 and incidence of heart failure in older adults: The Cardiovascular Health Study
Glazer, N. L., Macy, E. M., Lumley, T., Smith, N. L., Reiner, A. P., Psaty, B. M., King, G. L., Tracy, R. P., & Siscovick, D. S. (2012) · Cytokine · doi:10.1016/j.cyto.2012.07.013 · Cited by 14
Technology-Assisted Congestive Heart Failure Care
Iyngkaran, P., Toukhsati, S. R., Biddagardi, N., Zimmet, H., Atherton, J. J., & Hare, D. L. (2015) · Current Heart Failure Reports · doi:10.1007/s11897-014-0251-3 · Cited by 14
Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells
Wang, H., Xi, Y. T., Zheng, Y., Wang, X., & Cooney, A. J. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.02.032 · Cited by 15
Extracorporeal Ultrafiltration for Acute Heart Failure: Lost Battle or Lasting Opportunity?
Koratala, A., & Kazory, A. (2016) · Blood Purification · doi:10.1159/000451054 · Cited by 14
N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy
Giam, B., Kuruppu, S., Chu, P., Smith, A. I., Marques, F. Z., Fiedler, A., Horlock, D., Kiriazis, H., Du, X., Kaye, D. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17927-5 · Cited by 14
In vitro and in vivo differentiation of induced pluripotent stem cells generated from urine-derived cells into cardiomyocytes
Jiang, Y., Chen, M., Zhang, N., Yang, H.-J., Rui, Q., & Zhou, Y. (2017) · Biology Open · doi:10.1242/bio.029157 · Cited by 14
Videoconferencing for Management of Heart Failure: An Integrative Review
Bauce, K., Fahs, D. B., Batten, J., & Whittemore, R. (2018) · Journal of Gerontological Nursing · doi:10.3928/00989134-20180207-01 · Cited by 15
Importance of elevated heart rate in the very early phase of ST-segment elevation myocardial infarction: Results from the DANAMI-3 trial
Nepper‐Christensen, L., Lønborg, J., Ahtarovski, K. A., Høfsten, D. E., Kyhl, K., Schoos, M. M., Göransson, C., Laursen, P. N., Sadjadieh, G., Ghotbi, A. A., et al. (2018) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872618795515 · Cited by 14
Positionspapier Telemonitoring
Arbeitsgruppe 33/Telemonitoring in der Deutschen Gesellschaft für Kardiologie, H. U. K. E. V. (. U. A. M., Helms, T. M., Stockburger, M. A., Koehler, F., Leonhardt, V., Muller, A. M., Rybak, K., Sack, S., Schwab, J. O., Zugck, C., et al. (2019) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-019-0630-2 · Cited by 13
Reactive oxygen species during heart regeneration in zebrafish: Lessons for future clinical therapies
Helston, O., & Amaya, E. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12892 · Cited by 13
Experiences and Perceptions of Patients and Providers Participating in Remote Titration of Heart Failure Medication Facilitated by Telemonitoring: Qualitative Study
Artanian, V., Ware, P., Rac, V. E., Ross, H. J., & Seto, E. (2021) · JMIR Cardio · doi:10.2196/28259 · Cited by 16
Dirty Jobs: Macrophages at the Heart of Cardiovascular Disease
Stevens, T. W., Khalaf, F. K., Soehnlen, S. M., Hegde, P., Storm, K., Meenakshisundaram, C., Dworkin, L. D., Malhotra, D. K., Haller, S. T., Kennedy, D. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10071579 · Cited by 13
Aerobic Exercise as an Adjunct Therapy for Improving Cognitive Function in Heart Failure
GARY, R. A., & Brunn, K. (2014) · Cardiology Research and Practice · doi:10.1155/2014/157508 · Cited by 15
Air Travel Considerations for the Patients With Heart Failure
Izadi, M., Alemzadeh‐Ansari, M. J., Kazemi-Saleh, D., & Farahani, M. M. (2014) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.17213 · Cited by 14
Chronic heart failure and mortality in patients with community-acquired Staphylococcus aureus bacteremia: a population-based cohort study
Smit, J., Adelborg, K., Thomsen, R. W., Søgaard, M., & Schønheyder, H. C. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1570-7 · Cited by 14
Extracellular vesicles in post-infarct ventricular remodelling
Gąsecka, A., van der Pol, E., Nieuwland, R., & Stępień, E. Ł. (2017) · Kardiologia Polska · doi:10.5603/kp.a2017.0178 · Cited by 14
The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea
Hong, S.-H., Lee, J., Park, S., Nam, J. H., Song, H. J., Park, S.-Y., & Lee, E. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0659-8 · Cited by 14
Management of advanced heart failure: a review
Kalmanovich, E., Audurier, Y., Akodad, M., Mourad, M., Battistella, P., Agullo, A., Gaudard, P., Colson, P. H., Rouvière, P., Albat, B., et al. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1530112 · Cited by 17
The incremental economic burden of heart failure: A population-based investigation from South Korea
Cho, H., Oh, S.-H., Lee, H., Cho, H.-J., & Kang, H.-Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208731 · Cited by 15
Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction With the Use of Electrocardiographic Artificial Intelligence: A Cost-Effectiveness Approach
Liu, W.-T., Hsieh, P.-H., Lin, C.-S., Fang, W.-H., Wang, C.-H., Tsai, C.-S., Hung, Y.-J., Hsieh, C.-B., Lin, C., & Tsai, D.-J. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.11.044 · Cited by 15
[Retracted] Changes in Expressions of HSP27, HSP70, and Soluble Glycoprotein in Heart Failure Rats Complicated with Pulmonary Edema and Correlations with Cardiopulmonary Functions
Hong, Y.-C., Wang, Z., Rao, Z.-P., Wan, J., Ling, X., & Zheng, Q. (2021) · BioMed Research International · doi:10.1155/2021/6733341 · Cited by 13
Retracted
Combination Diuretic Therapy With Thiazides: A Systematic Review on the Beneficial Approach to Overcome Refractory Fluid Overload in Heart Failure
Gogikar, A., Nanda, A., Janga, L. S. N., Sambe, H. G., Yasir, M. B., Man, R. K., & Mohammed, L. (2023) · Cureus · doi:10.7759/cureus.44624 · Cited by 13
Yoga as Adjunct Therapy for Chronic Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Dutta, A., Mooventhan, A., & Nivethitha, L. (2023) · Avicenna Journal of Medicine · doi:10.1055/s-0043-1774738 · Cited by 13
Exogenous Transforming Growth Factor-β1 and Its Helminth-Derived Mimic Attenuate the Heart's Inflammatory Response to Ischemic Injury and Reduce Mature Scar Size
Redgrave, R. E., Singh, E., Tual‐Chalot, S., Park, C., Hall, D. H., Bennaceur, K., Smyth, D. J., Maizels, R. M., Spyridopoulos, I., & Arthur, H. M. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.09.014 · Cited by 15
The Interplay of Comorbidities in Chronic Heart Failure: Challenges and Solutions
Agress, S., Sheikh, J. S., Ramos, A. A. P., Kashyap, D., Razmjouei, S., Kumar, J., Singh, M., Lak, M. A., Osman, A., & Haq, M. Z. U. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x289572240206112303 · Cited by 16
Emerging Epigenetic Therapies for the Treatment of Cardiac Fibrosis
Garitano, N., Aguado‐Alvaro, L. P., & Pelacho, B. (2025) · Biomedicines · doi:10.3390/biomedicines13051170 · Cited by 13
Complications and 1-year benefit of cardiac resynchronization therapy in patients over 75 years of age — Insights from the German Device Registry
Köbe, J., Andresen, D., Maier, S., Stellbrink, C., Kleemann, T., Gonska, B., Reif, S., Hochadel, M., Senges, J., & Eckardt, L. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.212 · Cited by 13
The association of heart failure-related microRNAs with neurohormonal signaling
Chen, Y., Wang, J., Tong, K. S., Wong, L. L., Liew, O. W., & Richards, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.019 · Cited by 13
Integrative Medicine and Cardiovascular Disorders
Mehta, D. H. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.02.005 · Cited by 13
Improvement of Myocardial Function Following Catheter-Based Renal Denervation in Heart Failure
Liao, S.-Y., Zhen, Z., Liu, Y., Au, K. W., Lai, W., Tsang, A. M.-C., & Tse, H. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.03.009 · Cited by 14
A moderate 1-km treadmill walk predicts mortality in men with mid-range left ventricular dysfunction
Mandini, S., Grazzi, G., Mazzoni, G., MYERS, J. N., Pasanisi, G., Sassone, B., Conconi, F., & Chiaranda, G. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317722434 · Cited by 13
Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by 123I-mIBG scintigraphy in patients with heart failure with reduced ejection fraction submitted to cardiac resynchronization therapy
Cruz, M. C., Abreu, A., Portugal, G., Clara, S., Cunha, P. S., Oliveira, M., Santos, V., Oliveira, L., Rio, P., Rodrigues, I., et al. (2017) · Journal of Nuclear Cardiology · doi:10.1007/s12350-017-1148-9 · Cited by 13
Ivabradine as adjuvant treatment for chronic heart failure
Benstoem, C., Kalvelage, C., Breuer, T., Heussen, N. M., Marx, G., Stoppe, C., & Brandenburg, V. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013004.pub2 · Cited by 14
Hyperkalaemia in Heart Failure—Pathophysiology, Implications and Therapeutic Perspectives
Llubani, R., Vukadinović, D., Werner, C. M., Marx, N., Zewinger, S., & Böhm, M. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0413-9 · Cited by 13
Safety, tolerability, pharmacokinetics and pharmacodynamics of parenterally administered dutogliptin: A prospective dose‐escalating trial
Buchtele, N., Schwameis, M., Schoergenhofer, C., Derhaschnig, U., Firbas, C., Karch, R., Nix, D., Schenk, R., & Jilma, B. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14208 · Cited by 13
Bioengineering Methods in MicroRNA-Mediated Direct Reprogramming of Fibroblasts Into Cardiomyocytes
Paoletti, C., & Chiono, V. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.750438 · Cited by 13
Combined levosimendan and Sacubitril/Valsartan markedly protected the heart and kidney against cardiorenal syndrome in rat
Sung, P., Chai, H., Yang, C., Chiang, J. Y., Chen, C., Chen, Y., & Yip, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112745 · Cited by 13
Targeting Epigenetic Regulation of Cardiomyocytes through Development for Therapeutic Cardiac Regeneration after Heart Failure
Kraus, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911878 · Cited by 13
Comparative Analysis of Methods to Induce Myocardial Infarction in a Closed-Chest Rabbit Model
Isorni, M., Casanova, A., Piquet, J., Bellamy, V., Pignon, C., Puymirat, É., & Menasché, P. (2015) · BioMed Research International · doi:10.1155/2015/893051 · Cited by 13
The Practical Role of Echocardiography in Selection, Implantation, and Management of Patients Requiring LVAD Therapy
Todaro, M. C., Khandheria, B. K., Paterick, T. E., Umland, M. M., & Thohan, V. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0468-5 · Cited by 13
Heart failure in older adults: embracing complexity.
Pirmohamed, A. M., Kitzman, D. W., & Maurer, M. S. (2016) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2016.01.020 · Cited by 13
Myocardial Viability and Revascularization: Current Understanding and Future Directions
Patel, P., Ivanov, A. V., & Ramasubbu, K. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0582-5 · Cited by 13
Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective
Ademi, Z., Pasupathi, K., & Liew, D. (2016) · Medicine · doi:10.1097/md.0000000000003531 · Cited by 14
Temporal trends in long-term mortality of patients with acute heart failure: Data from 1985–2008
van den Berge, J. C., Akkerhuis, M. K., Constantinescu, A. A., Kors, J. A., van Domburg, R. T., & Deckers, J. W. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.062 · Cited by 13
3-Chlorodiphenylamine activates cardiac troponin by a mechanism distinct from bepridil or TFP
Tikunova, S. B., Cuesta, A. F., Price, M. V., Li, M. X., Belevych, N., Biesiadecki, B. J., Reiser, P. J., Hwang, P. M., & Davis, J. P. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201812131 · Cited by 13
A Prospective, Multicenter, Post-Marketing Surveillance Study to Evaluate the Safety and Effectiveness of Tolvaptan in Patients with Reduced, Preserved, and Mid-Range Ejection Fraction Heart Failure
Kinugawa, K., Sato, N., Inomata, T., Yasuda, M., Shimakawa, T., & Fukuta, Y. (2019) · International Heart Journal · doi:10.1536/ihj.18-671 · Cited by 13
Decreased albumin is associated with elevated N-terminal pro-brain natriuretic peptide and poor long-term prognosis in patients with chronic heart failure
Yi, S., & Chen, M. (2020) · Medicine · doi:10.1097/md.0000000000023872 · Cited by 13
Carbonic anhydrase IX and hypoxia-inducible factor 1 attenuate cardiac dysfunction after myocardial infarction
Nolly, M. B., Vargas, L. A., Correa, M. V., Lofeudo, J. M., Pinilla, O. A., Rueda, J. O. V., Guerrero-Gimenez, M. E., Swenson, E. R., Damiani, M. T., & Álvarez, B. V. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02592-5 · Cited by 12
Ceramide and phosphatidylcholine lipids‐based risk score predicts major cardiovascular outcomes in patients with heart failure
Witoslawska, A., Meessen, J. M. T. A., Hilvo, M., Jylhä, A., Zannad, F. M., Cerrato, M., Rossignol, P., Novelli, D., Duarte, K., Targher, G., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14359 · Cited by 12
Investigating Death Anxiety and its Relationship with Some Demographic Variables in Patients with Heart Failure in Zanjan 2018
Asgari, S., Roohani, M., Amini, K., & Faghihzadeh, S. (2018) · Preventive Care In Nursing and Midwifery Journal · doi:10.29252/pcnm.8.2.34 · Cited by 12
Comparison of learning needs priorities between healthcare providers and patients with heart failure
Min, D., Park, J., Choi, E., & Ahn, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239656 · Cited by 12
Causas de muerte en pacientes hospitalizados en servicios de medicina interna por insuficiencia cardíaca según la fracción de eyección. Registro RICA
Espartero, M. E. G., Salamanca‐Bautista, P., Aramburu‐Bodas, Ó., Manzano, L., Simón, M. A. Q., Ormaechea, G., García, S. C., García, M. G., Rodrigo, J. M. C., Montero-Pérez-Barquero, M., et al. (2021) · Medicina Clínica · doi:10.1016/j.medcli.2020.10.022 · Cited by 12
Differences According to Age in the Diagnostic Performance of Cardiac Biomarkers to Predict Frailty in Patients with Acute Heart Failure
Iglesias, L. A., Merino‐Merino, A., Sánchez-Corral, E., Garcia‐Sanchez, M., Santos‐Sanchez, I., Saez‐Maleta, R., & Pérez-Rivera, J.-Á. (2022) · Biomolecules · doi:10.3390/biom12020245 · Cited by 12
Oral and gut microbiome alterations in heart failure: Epidemiology, pathogenesis and response to advanced heart failure therapies
yuzefpolskaya, M., Bohn, B., Ladanyi, A., Khoruts, A., Colombo, P. C., & Demmer, R. T. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.12.009 · Cited by 12
New Drug Targets and Preclinical Modelling Recommendations for Treating Acute Myocardial Infarction
Cao, Y., Redd, M. A., Chen, F., Mizikovsky, D., Li, X., Macdonald, P. S., King, G. F., & Palpant, N. J. (2023) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.12.015 · Cited by 12
Fenofibrate reduces cardiac remodeling by mitochondrial dynamics preservation in a renovascular model of cardiac hypertrophy
Castiglioni, L., Gelosa, P., Muluhie, M., Mercuriali, B., Rzemieniec, J., Gotti, M., Fiordaliso, F., Busca, G. A., & Sironi, L. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176767 · Cited by 12
Diagnostic and Therapeutic Practice for HFpEF Across Continents and Regions: An International Survey
Ingimarsdóttir, I. J., Vishram‐Nielsen, J. K. K., Einarsson, H., Goldfeder, S., Mewton, N., Barasa, A. L., Basic, C., Oerlemans, M. I. F. J., Niederseer, D., Shchendrygina, A., et al. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15084 · Cited by 11
Recombinant Klotho administration after myocardial infarction reduces ischaemic injury and arrhythmias by blocking intracellular calcium mishandling and CaMKII activation
Vázquez‐Sánchez, S., Blasco, A., Corredoira, P. M. F., Cantolla, P., Mercado‐García, E., Rodríguez‐Sánchez, E., González‐Lafuente, L., Poveda, J., González‐Moreno, D., Muñoz, A. M., et al. (2025) · The Journal of Pathology · doi:10.1002/path.6388 · Cited by 12
The relation between C-reactive protein (CRP) and risk of incident heart failure in patients with cardiovascular disease: a narrative review
Fatima, Z., Shakeel, R., Chaudhry, S. A. A., Qadri, M., Kakar, A. I., Ahmad, B., Ahmad, T., & Akilimali, A. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003455 · Cited by 12
Skin tissue regeneration by Acanthus dioscoridis L. leaf extracts in vivo: Relevance to transforming growth factor β 1, antioxidants, and inflammatory factors
Ahmed, K. A., Alqaisi, K. M., Ibrahim, N. A., Jabbar, A. A., Althagbi, H. I., Hassan, R. R., Saleh, G. N., Al-Dabhawi, A. H., Al‐Saleem, M. S. M., Abdullah, F. O., et al. (2025) · Burns · doi:10.1016/j.burns.2025.107690 · Cited by 12
β Subunits Functionally Differentiate Human Kv4.3 Potassium Channel Splice Variants
Abbott, G. W. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00066 · Cited by 12
Validación para Colombia del cuestionario para la “Medición de la capacidad funcional en pacientes con falla cardíaca”
Ropero, E. M. S., Vera-Giraldo, C. Y., Navas-Ríos, C. M., Ortiz-Rangel, S. D., Guevara, C. R., Vargas-Montoya, D. M., Aguirre-Acevedo, D. C., & Lugo‐Agudelo, L. H. (2018) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2018.04.004 · Cited by 12
Identification of time‑series differentially expressed genes and pathways associated with heart failure post‑myocardial infarction using integrated bioinformatics analysis
Li, X., Li, B., & Jiang, H. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10190 · Cited by 12
Rehabilitation Intervention for Individuals With Heart Failure and Fatigue to Reduce Fatigue Impact: A Feasibility Study
Kim, Y. J., Radloff, J. C., Crane, P. B., & Bolin, L. P. (2019) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2019.43.6.686 · Cited by 15
The Effect of 3-Month Growth Hormone Administration and 12-Month Follow-Up Duration among Heart Failure Patients Four Weeks after Myocardial Infarction: A Randomized Double-Blinded Clinical Trial
Amirpour, A., Vakhshoori, M., Zavar, R., Zarei, H., Sadeghi, M., & Yavari, B. (2021) · Cardiovascular Therapeutics · doi:10.1155/2021/2680107 · Cited by 12
Mid- to Late-Life Inflammation and Risk of Cardiac Dysfunction, HFpEF and HFrEF in Late Life
Cohen, A., TERAMOTO, K., Claggett, B. L., Buckley, L. F., Solomon, S. D., Ballantyne, C. M., Selvin, E., & Shah, A. M. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.07.006 · Cited by 12
Associations between biomarkers of multimorbidity burden and mortality risk among patients with acute dyspnea
Wessman, T., Tofik, R., Ruge, T., & Melander, O. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02825-6 · Cited by 12
Economic Outcomes of Rehabilitation Therapy in Older Patients With Acute Heart Failure in the REHAB-HF Trial
Chew, D. S., Li, Y., Zeitouni, M., Whellan, D. J., Kitzman, D. W., Mentz, R. J., Duncan, P. W., Pastva, A. M., Reeves, G. R., Nelson, M. B., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.4836 · Cited by 12
Pathophysiology of heart failure and an overview of therapies
Ranek, M. J., Berthiaume, J. M., Kirk, J. A., Lyon, R. C., Sheikh, F., Jensen, B. C., Hoit, B. D., BUTANY, J. W., Tolend, M., Rao, V. A., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822224-9.00025-6 · Cited by 14
Role of micronutrients in congestive heart failure: A systematic review of randomized controlled trials
Kkeveetil, C. V., Thomas, G., & Sam Johnson Udaya Chander, J. (2016) · Tzu Chi Medical Journal · doi:10.1016/j.tcmj.2016.08.001 · Cited by 12
Ambulatory pulmonary artery pressure monitoring in advanced heart failure patients
Yandrapalli, S., Raza, A., Tariq, S., & Aronow, W. S. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i1.21 · Cited by 12
Epidemiologic burden of hospitalisation for congestive heart failure among adults aged ≥19 years in the Philippines
Tumanan-Mendoza, B. A., Mendoza, V. L., Santos, A. A. A. B.-D., Punzalan, F. E. R., Pestaño, N. S., Natividad, R. B., Shiu, L. A., & Macabeo, R. (2017) · Heart Asia · doi:10.1136/heartasia-2016-010862 · Cited by 12
Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients
Marino, V. S. P., Dumont, S. M., Mota, L. D. G., Braga, D. D. S., de Freitas, S. S., & Moreira, M. D. C. V. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180124 · Cited by 12

Authors: Roger, V. L.
Affiliations: From the Department of Health Sciences Research and Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2013-08-30
Volume: 113
Issue: 6
Pages: 646-659
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/circresaha.113.300268
PMC: PMC3806290
OpenAlex: W2168048360
Cited by: 1,728
References: 160
Citations by year: 2026: 43 · 2025: 63 · 2024: 101 · 2023: 126 · 2022: 142 · 2021: 179 · 2020: 170 · 2019: 198 · 2018: 183 · 2017: 217 · 2016: 128 · 2015: 78 · 2014: 59 · 2013: 27
FWCI: 66.22
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL59205, R01HL059205, R01HL072435, R01 HL-72435)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
Keywords: heart failure, heart failure epidemiology, heart failure hospitalization, heart failure readmission, predictors of readmission, multimorbidity, heart failure with preserved ejection fraction, heart failure mortality, health care expenditure, community-based care, patient-centered care
MeSH terms: Female, Heart Failure, Hospitalization, Humans, Male, Risk Factors, Incidence, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Epidemiology of Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks